WEN-JEN HWU to Pyridines
This is a "connection" page, showing publications WEN-JEN HWU has written about Pyridines.
Connection Strength
0.112
-
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors. JCI Insight. 2018 02 22; 3(4).
Score: 0.096
-
Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma. Clin Cancer Res. 2012 Feb 15; 18(4):1120-8.
Score: 0.016